Alcoholic hepatitis G-CSF, which did not respond to steroids, was effective
A new study has found that adding granulocyte colony stimulating factor (G-CSF) to steroids in the treatment of severe alcoholic hepatitis could improve a patient’s 90-day survival rate. The results of a study examining the effects of co-administration of steroids and G-CSF were announced on the 6th at the AASLD Annual Meeting 2022. In patients … Read more